迈博药业有限公司（股票名称：迈博药业-B，股票代码：02181）于2026年8月4日发布了截至2026年7月31日的证券变动月报表。
报告显示，截至2026年7月31日，公司法定/注册股本数量维持为50,000,000,000股，面值为每股0.0001美元，法定/注册股本总额为5,000,000美元，与上月持平。已发行普通股数量为4,124,080,000股，库藏股份数量为0股，合计4,124,080,000股，期内无新增发行或购回注销活动。公司现有员工持股计划相关的购股权数量为72,670,876股，本月未发生授出、行使或失效变动。
公司表示，其本月已充分符合香港联合交易所有限公司的相关公众持股量要求。截至本月末，股本结构保持不变，未出现新的发行及回购情况。根据公告信息，本月报表由公司秘书曾浩贤先生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.